BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 32041923)

  • 1. Practical Guidelines Management of Graves Ophthalmopathy.
    Subekti I; Soewondo P; Soebardi S; Darmowidjojo B; Harbuwono DS; Purnamasari D; Tarigan TJE; Wisnu W; Tahapary DL; Kurniawan F; Sidik M; Nusanti S; Dewiputri S; Suharko H; Suardana GG; Suroyo I; Wulani V; Siswoyo AD; Gondhowiardjo S; Kodrat H
    Acta Med Indones; 2019 Oct; 51(4):364-371. PubMed ID: 32041923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation and treatment of graves ophthalmopathy.
    Stan MN; Garrity JA; Bahn RS
    Med Clin North Am; 2012 Mar; 96(2):311-28. PubMed ID: 22443978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Graves' Orbitopathy].
    Eckstein A; Esser J; Mattheis S; Berchner-Pfannschmidt U
    Klin Monbl Augenheilkd; 2016 Dec; 233(12):1385-1407. PubMed ID: 27871109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Graves' ophthalmopathy].
    Eckstein A; Dekowski D; Führer-Sakel D; Berchner-Pfannschmidt U; Esser J
    Ophthalmologe; 2016 Apr; 113(4):349-64; quiz 465-6. PubMed ID: 27059986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR; van Zeijl CJ; Boelen A; Kloos R; Saeed P; Vriesendorp TM; Mourits MP
    Neth J Med; 2011; 69(7):302-8. PubMed ID: 21934174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy and radiotherapy in Graves' orbitopathy].
    Beisse F; Lagrèze WA; Schmucker M
    Ophthalmologe; 2011 May; 108(5):425-31. PubMed ID: 21590352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Graves' ophthalmopathy.
    González-García A; Sales-Sanz M
    Med Clin (Barc); 2021 Feb; 156(4):180-186. PubMed ID: 33069387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.
    Guler OC; Onal C; Arslan G
    Wien Klin Wochenschr; 2016 Apr; 128(7-8):299-303. PubMed ID: 26466836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Graves' ophthalmopathy].
    Eckstein A; Esser J
    Internist (Berl); 2010 May; 51(5):584, 586-8, 590-2, passim. PubMed ID: 20383481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on endocrine orbitopathy].
    Ponto KA; Kahaly GJ; Pitz S
    Klin Monbl Augenheilkd; 2009 Feb; 226(2):R13-28; quiz R29-31. PubMed ID: 19206039
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral conjunctivitis interfering with the clinical activity score and management of thyroid ophthalmopathy.
    Boboridis KG; Konstas AG; Krassas GE; Georgiadis NS
    Orbit; 2006 Mar; 25(1):27-9. PubMed ID: 16527772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current management of endocrine orbitopathy].
    Ponto KA; Kahaly GJ
    Med Klin (Munich); 2008 Oct; 103(10):717-30; quiz 729-30. PubMed ID: 18936897
    [No Abstract]   [Full Text] [Related]  

  • 13. [Update on endocrine orbitopathy].
    Eckstein A; Berchner-Pfannschmidt U; Führer D; Esser J
    Ophthalmologe; 2013 Nov; 110(11):1079-96. PubMed ID: 24231915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of graves' orbitopathy after treatment.
    Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M
    Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Rinsho; 2006 May; Suppl 1():307-10. PubMed ID: 16776151
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
    Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC
    Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the MRI and clinical features of Asian Graves' ophthalmopathy by radiation therapy with steroids.
    Ma Z; Ozaki H; Ishikawa Y; Jingu K
    Jpn J Radiol; 2019 Aug; 37(8):612-618. PubMed ID: 31201593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.
    Sisti E; Menconi F; Leo M; Profilo MA; Mautone T; Mazzi B; Rocchi R; Latrofa F; Nardi M; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2015 Jun; 38(6):661-8. PubMed ID: 25596664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixing modalities: exploring the options for Graves' ophthalmopathy.
    Cockram CS
    Hong Kong Med J; 2005 Oct; 11(5):320-1. PubMed ID: 16219948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.